Institutional investors purchased a net $440.2 thousand shares of ELOS during the quarter ended December 2012, and now own 71.54% of the total float, a percentage that is typical for companies in the Medical Specialties industry.
| Other institutional | 55.57% |
| Mutual fund holders | 15.97% |
| Individual stakeholders | -- |